Featured
Last news
Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced that its drug candidate NV-387 is the weapon necessary for combatting growing cases of measles worldwide, especially in the industrialized world including, USA, Canada, UK, and European Union.
Forward Water Technologies Announces Financial Results for the Fifteen-Month Period Ended March 31, 2025
TORONTO, ON / ACCESS Newswire / July 30, 2025 / Forward Water Technologies Corp. (TSXV:FWTC) (the "Company") is pleased to announce that it has filed its condensed consolidated audited financial statements and related management's discussion and analysis for the fifteen-month period ended March 31, 2025. Copies of these financial statements and related management's discussion and analysis can be found on the Company's issuer profile at www.sedar.com. All financial information in this news release is reported in Canadian dollars, unless otherwise indicated.
South Dakota Partners with Avel eCare to Launch the First-of-Its-Kind Continuing Education (CE) Program for EMS Teams Using Real-Time Telemedicine Support
SIOUX FALLS, SD / ACCESS Newswire / July 30, 2025 / The South Dakota Department of Health in partnership with Avel eCare, a national leader in innovative telemedicine solutions, is proud to introduce a new and uniquely impactful continuing education (CE) credit opportunity for emergency medical services professionals. Beginning August 25, EMS personnel who engage Avel for a telemedicine encounter will be eligible to earn CE credit - marking a first in virtual care.
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, durable effect, and comparable efficacy to injected morphine across both pain phases
Specificity Expands to Europe, Bringing Precision Targeting and Human-Only Ad Tech to a Market Ripe for Disruption
TAMPA, FLORIDA / ACCESS Newswire / July 30, 2025 / Specificity, Inc. (OTCID:SPTY), the digital marketing powerhouse known as the nation's first, truly hybrid model for adtech and digital marketing, has very quietly launched Specificity Europe-bringing its proprietary, hyper-targeted ad tech to a market often overlooked by mar-tech due to GDPR regulations.
DEA's Marijuana Hypocrisy Laid Bare: As Rescheduling Looms, Agency's Ethical Failures and Research Obstruction Spark Outrage
Terrance Cole's First Test as AdministratorMMJ BioPharma Cultivation's case exposes DEA's Diversion Control Division as a cartel of obstructionists who have abandoned science, betrayed public trust, and refused to follow the law.New DEA Administrator Terrance Cole inherited a mess. But now he has a chance to do something Judge Mulrooney, Thomas Prevoznik, Matthew Straitand Aarathi Haig never would: Tell the truth. Follow the law. And approve MMJ's long-blocked registration so clinical trials can finally begin.
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
HAMBURG, DE / ACCESS Newswire / July 30, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces the signing of a non-binding agreement with Sandoz AG (SIX:SDZ)(OTCQX:SDZNY) regarding the potential sale of Just - Evotec Biologics EU in Toulouse, France, for a consideration of about US$ 300 m in cash. In addition, the planned transaction terms include further technology related consideration, future development revenues, milestones and product royalties.
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
Evotec SE and Sandoz AG signed a non-binding term sheet on a planned sale of Just - Evotec Biologics EU in Toulouse to SandozUnder the proposed deal Evotec would transfer biosimilar manufacturing capabilities to enable Sandoz to produce biosimilar medicines using Just - Evotec Biologics' advanced continuous manufacturing technologyThe deal terms include the purchase price of the site for around US$ 300 m in cash, and in addition will include further technology related consideration, future development revenues, milestones and product royaltiesPlanned transaction marks major milestone in Evotec's strategy to create asset-lighter business model leveraging high-margin offerings, with Just - Evotec Biologics remaining core business for EvotecTransaction is expected to immediately improve Evotec's short-, mid-, and long-term revenue mix, profit margins, and capital efficiency
Tens of thousands of Catholics head to Vatican's Jubilee of Youth
Pope Leo XIV made a surprise appearance in a crowd of 120,000 young Catholics who gathered on Tuesday in Rome for the Vatican's Jubilee of Youth -- an event that takes place every 25 years.
Trump says fell out with Epstein because he was taking Mar-a-Lago spa staff
US President Donald Trump said Tuesday that he fell out with Jeffrey Epstein because the convicted sex offender had poached staff from his club's spa, including the woman at the center of an underage sex scandal involving Prince Andrew.
Tens of thousands in Rome for Vatican's Jubilee of Youth
Tens of thousands of young Catholics from all over the world gathered on Tuesday in Rome for a week of pilgrimage during the Vatican's Jubilee of Youth -- an event that takes place every 25 years.
New York mass shooter blamed NFL for his brain injuries
A man who killed four people, then committed suicide in a New York skyscraper, may have been targeting the NFL offices there because he blamed the American football league for brain injuries he said he suffered, Mayor Eric Adams said Tuesday.
LA wildfires push insurance losses to highest since 2011: Munich Re
The Los Angeles wildfires drove insured natural disaster losses in the first half of the year to their highest level since Japan's Fukushima disaster in 2011, German reinsurance giant Munich Re said Tuesday.
Five dead including gunman in New York office shooting spree
Four people including a police officer were killed Monday after a gunman walked into a skyscraper in central Manhattan and opened fire in broad daylight, officials said.
Five dead including gunman in New York office shooting
At least four people including a police officer were killed Monday after a gunman walked into a skyscraper in central Manhattan and opened fire in broad daylight, officials said.
Five dead after New York Midtown shooting: US media
Five people including a police officer and the suspected gunman were dead following a shooting Monday in central Manhattan, US media reported.
Gunman dead in New York after Midtown shooting: police
A gunman was dead Monday following a shooting in central Manhattan, New York police said, amid reports a police officer was killed and several civilians struck, provoking a lockdown in the area.
Omega Protein and Ocean Harvesters Urge Science-Based Review Before Imposing New Menhaden Restrictions
Letter from Veteran Biologist Addresses Scientific Questions Over Osprey Declines
What to Do When a Loved One Refuses Help for Mental Illness or Addiction
Reflection Family Interventions and The Family Recovery Foundation Launch Groundbreaking 24-Week Family Recovery Curriculum
RightEdition.com: A Voice of Reason and Common Sense
LAS VEGAS, NEVADA / ACCESS Newswire / July 29, 2025 / RightEdition.com has become a widely followed online platform known for its unapologetic voice of reason and old-fashioned good sense.
Be Your Best and AllStar Global Brands / AllStar Health Brands Ltd sign a 1-Year contract
Be Your Best and AllStar Global Brands / AllStar Health Brands Ltd Announce Strategic Three-Part Partnership to Launch World-Leading AI Soccer Training Platform. Project is expected to generate $250,000 in Annual Revenue from Launch
MDCE's Real Game Used Unlocks Investment Potential Through Historic Sports Memorabilia Boom
MESA, ARIZONA / ACCESS Newswire / July 29, 2025 / Real Game Used (RGU), a leading sports memorabilia authentication firm and a proud subsidiary of Medical Care Technologies Inc. (OTC Pink:MDCE), is excited to announce the upcoming showcase of recently authenticated memorabilia worth hundreds of thousands of dollars' via its official Instagram and Twitter accounts.
Ambience Healthcare Announces $243 Million Series C to Scale its AI Platform for Health Systems
Oak HC/FT and Andreessen Horowitz (a16z) co-lead investment to accelerate the deployment of Ambience's AI platform to transform clinical and administrative workflows for health systems across the country.
South of France Based Independent Label Kaa Production / Sidekick Music Goes Global: Canadian Singer Yzabo's "Afterglow" Ignites $509.7m Blockbuster F1 the Movie
The sync in Joseph Kosinski's film starring Brad Pitt showcases KAA Production's expertise in music supervision and licensing.
LTNC's LOCK'DIN Partners with Fortune 10 Leader Cencora; Portion of Proceeds to Benefit Manny Pacquiao Foundation
JACKSON, WY / ACCESS Newswire / July 29, 2025 / Labor Smart, Inc. (OTCID:LTNC), a Wyoming‑based publicly traded company, today announced a landmark partnership for its functional hydration brand LOCK'DIN® with Cencora, one of the world's largest pharmaceutical companies. The collaboration will place LOCK'DIN Hydrogen Water and Electrolyte Stick Packs onto Cencora's B2B distribution platform, giving the brand access to tens of thousands of pharmacies, clinics, hospitals, and retail doors - representing the most significant growth milestone in LOCK'DIN's history.
RMTG Expands to Northern Argentina and Paraguay with New Affiliate Partnership
Former Minister of Health Brings Institutional Leadership to Expand Affiliate Network Across Key Latin American Markets
Ovation Science Expands with Planet 13 into Florida
Expanded License Agreement Brings Ovation's Science-Based Topicals to Largest Medical Cannabis Market in the USA
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion as the Company prepares to launch U.S. Phase 2a by year-end
CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase
U.S. CBD market projected to exceed $36 billion by 2032 as foot traffic rebounds in top-tier malls with over 122 million monthly U.S. shoppers - CBDL strategically positioned at the intersection of both trends
Blankit Media Aims to Build Thousands of AI Influencers with AI-Powered Tools
Revolutionizing the Creator Economy with Scalable, Fully AI-Generated Content
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic hepatitisProposed acquisition strengthens Bausch Health's commitment to hepatology and patients suffering with liver disease complications globally
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / July 29, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2025 ended June 30, 2025, after the market closes on Thursday, August 7, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.